This is the first major guideline update since 2015, reflecting further advances in imaging technology and clinical information. The new recommendations cover everything from preferred imaging ...
Paramagnetic rim lesions may help assess MS risk in people with radiologically isolated syndrome before symptoms appear.
In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...
ETH Zurich researchers have developed a new method of magnetic resonance imaging (MRI) for the early detection and better monitoring of multiple sclerosis (MS). The method maps the myelin sheaths in ...
Top: 7T MRI at baseline (left) and 1.5-year follow-up (right) in a woman with secondary progressive MS, showing the development of two intracortical lesions. Bottom: 7T MRI at baseline (left) and ...
Dr. J. William Lindsey, Director of Multiple Sclerosis and Neuroimmunology at McGovern Medical School, UTHealth Houston, discusses how these social determinants of health impact the disease. (2:35) Is ...
December 12, 2008 — A new study following asymptomatic patients who were found to have anomalies highly suggestive of multiple sclerosis (MS) on magnetic resonance imaging (MRI) scans performed for ...
Siemens Healthineers and Biogen announced today that the companies plan to jointly develop Magnetic Resonance Imaging (MRI) applications with the intent of quantifying key markers of multiple ...
May 13, 2004 — Simvastatin at a dose of 80 mg is associated with reduced number and volume of multiple sclerosis (MS) lesions on magnetic resonance imaging (MRI) at six months, according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results